Clinical Trial

Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment

Study acronym: UPA-MEST
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective randomized controlled trial where quality of life and the effectiveness of treatment will be evaluated in 80 patients with confirmed unilateral primary aldosteronism ,randomly assigned to be either treated surgically with unilateral adrenalectomy or to receive medical treatment with eplerenone.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-30; most recent amendment 2025-04-03.
Status change: Not Yet Recruiting → Recruiting 2023-04-28
Trial Details
NCT Number NCT05797558
Lead Sponsor Göteborg University
Collaborators: Karolinska Institutet, Umeå University
Conditions Primary Hyperaldosteronism Due to Adrenal Adenoma
Enrollment 80 participants
Start Date 2023-04-28
Primary Completion 2028-05-28 (estimated)
Study Completion 2028-05-28 (estimated)
Updated on ClinicalTrials.gov 2025-04-06